Comprehensive, Focused, Fibromyalgia Care
GTM Strategy
Exploit AI-Optimized Content Gap
Exploit AI-Optimized Content Gap
Exploit AI-Optimized Content Gap
Virtually all content in the fibromyalgia space is light, outdated, and completely unprepared for the AI search revolution. Patients are underserved, and there are no "new shiny things" capturing attention.
- No AI-native telehealth solutions exist for fibromyalgia
- Content is not optimized for AI search or citation
- Patients average 4+ years to diagnosis
- 30% of in-clinic appointments are missed
- One-size-fits-all treatments drive poor outcomes
High-Value RWD
Exploit AI-Optimized Content Gap
Exploit AI-Optimized Content Gap
Real-world data from treatment journeys, EHRs (Electronic Health Records), and RPM (Remote Patient Monitoring) enables reimbursement prediction, informs wellness programs, and is highly sought after by pharmaceutical manufacturers, payers, providers, and wellness programs.
Plus, our ecosystem addresses this challenge: New "Top 30" drugs (ADCs, BiTEs) require 24/7 surveillance for side effects like cytokine release syndrome.
Scalability
Exploit AI-Optimized Content Gap
Scalability
Fibromyalgia is the first complex chronic condition we address. The next nine in the pipeline replicate this model and tech stack, and software plus training the LLMs is budgeted. Scales out to other regions, too. Correlating data with MENA countries that have very high fibromyalgia prevalence will almost certainly lead to insights.